Literature DB >> 26602099

The Toxicology Investigators Consortium Case Registry--the 2014 Experience.

Sean H Rhyee1, Lynn Farrugia2, Sharan L Campleman3, Paul M Wax3,4, Jeffrey Brent5.   

Abstract

The Toxicology Investigators Consortium (ToxIC) Case Registry was established in 2010 by the American College of Medical Toxicology. The Registry includes all medical toxicology consultations performed at participating sites. The Registry was queried for all cases entered between January 1 and December 31, 2014. Specific data reviewed for analysis included demographics (age, gender, ethnicity), source of consultation, reasons for consultation, agents involved in toxicological exposures, signs, symptoms, clinical findings, fatalities, and treatment. In 2014, 9172 cases were entered in the Registry across 47 active member sites. Females accounted for 51.1 % of cases. The majority (65.1 %) of cases were adults between the ages of 19 and 65. Caucasians made up the largest identified ethnic group (48.9 %). Most Registry cases originated from the inpatient setting (93.5 %), with a large majority of these consultations coming from the emergency department or inpatient admission services. Intentional and unintentional pharmaceutical exposures continued to be the most frequent reasons for consultation, accounting for 61.7 % of cases. Among cases of intentional pharmaceutical exposure, 62.4 % were associated with a self-harm attempt. Non-pharmaceutical exposures accounted for 14.1 % of Registry cases. Similar to the past years, non-opioid analgesics, sedative-hypnotics, and opioids were the most commonly encountered agents. Clinical signs or symptoms were noted in 81.9 % of cases. There were 89 recorded fatalities (0.97 %). Medical treatment (e.g., antidotes, antivenom, chelators, supportive care) was rendered in 62.3 % of cases. Patient demographics and exposure characteristics in 2014 Registry cases remain similar to prior years. The majority of consultations arose in the acute care setting (emergency department or inpatient) and involved exposures to pharmaceutical products. Among exposures, non-opioid analgesics, sedative/hypnotics, and opioids were the most frequently encountered. A majority of cases required some form of treatment, but fatalities were rare.

Entities:  

Keywords:  Epidemiology; Overdose; Poisonings; Surveillance

Mesh:

Year:  2015        PMID: 26602099      PMCID: PMC4675600          DOI: 10.1007/s13181-015-0507-7

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  8 in total

1.  The Toxicology Investigators Consortium (ToxIC) Registry.

Authors:  Paul M Wax; Kurt C Kleinschmidt; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2011-12

2.  The Toxicology Investigators Consortium Case Registry-the 2010 experience.

Authors:  Jeffrey Brent; Paul M Wax; Tayler Schwartz; Kurt C Kleinschmidt; Kristin Engebretsen; Michael Beuhler
Journal:  J Med Toxicol       Date:  2011-12

3.  Suicide and the surrogate.

Authors:  Mark John Neavyn
Journal:  J Med Toxicol       Date:  2014-03

4.  The Toxicology Investigators Consortium Case Registry--the 2012 experience.

Authors:  Timothy Wiegand; Paul Wax; Eric Smith; Katherine Hart; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2013-12

5.  The toxicology investigators consortium case registry-the 2013 experience.

Authors:  Sean H Rhyee; Lynn Farrugia; Timothy Wiegand; Eric A Smith; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2014-12

6.  The Toxicology Investigators Consortium Case Registry--the 2011 experience.

Authors:  Timothy J Wiegand; Paul M Wax; Tayler Schwartz; Yaron Finkelstein; Rachel Gorodetsky; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2012-12

7.  Acute Methylenedioxypyrovalerone Toxicity.

Authors:  Blake A Froberg; Michael Levine; Michael C Beuhler; Bryan S Judge; Philip W Moore; Kristin M Engebretsen; Nathanael J Mckeown; Christopher D Rosenbaum; Amy C Young; Daniel E Rusyniak
Journal:  J Med Toxicol       Date:  2015-06

8.  The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity.

Authors:  Joseph W Watkins; Evan S Schwarz; Anna M Arroyo-Plasencia; Michael E Mullins
Journal:  J Med Toxicol       Date:  2015-06
  8 in total
  6 in total

1.  The Toxicology Investigators Consortium Case Registry-the 2017 Annual Report.

Authors:  Lynn A Farrugia; Sean H Rhyee; Sharan L Campleman; Bryan Judge; Louise Kao; Anthony Pizon; Lauren Porter; Anne M Riederer; Timothy Wiegand; Diane Calello; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2018-08-09

Review 2.  The Toxicology Investigators Consortium Case Registry-the 2015 Experience.

Authors:  Lynn A Farrugia; Sean H Rhyee; Sharan L Campleman; Anne-Michelle Ruha; Timothy Weigand; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2016-08-12

3.  The Toxicology Investigators Consortium Case Registry-the 2016 Experience.

Authors:  Lynn A Farrugia; Sean H Rhyee; Diane P Calello; Sharan L Campleman; Anne M Riederer; Hannah R Malashock; Anthony Pizon; Timothy Wiegand; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2017-08-01

4.  The Toxicology Investigators Consortium Case Registry-the 2018 Annual Report.

Authors:  Meghan B Spyres; Lynn A Farrugia; A Min Kang; Diane P Calello; Sharan L Campleman; Anthony Pizon; Timothy Wiegand; Louise Kao; Brad D Riley; Shao Li; Paul M Wax; Jeffery Brent
Journal:  J Med Toxicol       Date:  2019-10-22

5.  Neuropsychiatric Sequelae in Adolescents With Acute Synthetic Cannabinoid Toxicity.

Authors:  Sarah Ann R Anderson; Anna M Oprescu; Diane Calello; Andrew Monte; Peter S Dayan; Yasmin L Hurd; Alex F Manini
Journal:  Pediatrics       Date:  2019-07-08       Impact factor: 7.124

Review 6.  The Role of Renal Replacement Therapy in the Management of Pharmacologic Poisonings.

Authors:  Aibek E Mirrakhimov; Aram Barbaryan; Adam Gray; Taha Ayach
Journal:  Int J Nephrol       Date:  2016-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.